Serum selenium and glutathione peroxidase in patients with obesity and metabolic syndrome

Pakistan Journal of Nutrition

Volumn 7, Issue 1, 2008, Pages 112-117

  Ghayour Mobarhan, Majid ^a,b   Taylor, Andrew ^c   Lanham New, Susan ^c   Lamb, David J ^c   Nezhad, Mohsen Azimi ^a   Kazemi Bajestani, Seyyed Mohammed Reza ^a   Ghafouri, Fahimeh ^a   Livingstone, Callum ^c,d   Wang, Tim ^c,d   Ferns, Gordon A A ^c,d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

GPx; Obesity and metabolic syndrome; Selenium

Indexed keywords

FREE RADICAL; GLUTATHIONE PEROXIDASE; SELENIUM;

ADULT; AGED; ANALYSIS OF COVARIANCE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CONTROLLED STUDY; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PROTEIN INTAKE; UNITED KINGDOM;

EID: 37349009905     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2008.112.117     Document Type: Article

References (20)

1. Alissa, E.M., S.M. Bahijri and G.A. Ferns, 2003. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med. Sci. Monit., 9: RA9-18.
2. Ford, E.S., 2005b. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care, 28: 2745-2749.
3. Ford, E.S., 2005a. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care, 28: 2745-2749.
4. Ford, E.S., A.H. Mokdad, W.H. Giles and D.W. Brown, 2003. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes, 52: 2346-2352.
5. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18:499-502.
6. Ghayour-Mobarhan, M., S.A. New, D.J. Lamb, B.J. Starkey, C. Livingstone, T. Wang., N. Vaidya and G.A. Ferns, 2005a. Dietary antioxidants and fat are associated with plasma antibody titers to heat shock proteins 60, 65 and 70 in subjects with dyslipidemia. Am. J. Clin. Nutr., 81: 998-1004.
7. Ghayour-Mobarhan, M., A. Taylor, S.A. New, D.J. Lamb and G.A. Ferns, 2005b. Determinants of serum copper, zinc and selenium in healthy subjects. Ann. Clin. Biochem., 42: 364-375.
8. Ghayour-Mobarhan, M., D.J. Lamb, A. Taylor, N. Vaidya, C. Livingstone, T. Wang and G.A. Ferns, 2005c. Effect of statin therapy on serum trace element status in dyslipidaemic subjects. Trace Elem. Med. Biol., 19: 61-7.
9. Gjorup, I., T. Gjorup and B. Andersen, 1988. Serum selenium and zinc concentrations in morbid obesity. Comparison of controls and patients with jejunoileal bypass. Scand. J. Gastroenterol., 23: 1250-1252.
10. James, P.T., 2004. Obesity: the worldwide epidemic. Clin. Dermatol., 22: 276-280.
11. James, P.T., N. Rigby and R. Leach, 2004. The obesity epidemic, metabolic syndrome and future prevention strategies. Eu. J. Cardiovasc. Prev. Rehabil., 11: 3-8.
12. Kardinaal, A.F., F.J. Kok, L. Kohlmeier, J.M. Martin-Moreno, J. Ringstad, J. Gomez-Aracena, V.P. Mazaev, M. Thamm, B.C. Martin, A. Aro, J. D. Kark, M. gado-Rodriguez, R.A. Riemersma,'. van, V and J.K. Huttunen, 1997. Association between toenail selenium and risk of acute myocardial infarction in European men. The EURAMIC Study. European Antioxidant Myocardial infarction and Breast Cancer. Am. J. Epidemiol., 145: 373-379.
13. Kok, F.J., A. Hofman, J.C. Witteman, A.M. de Bruijn, D.H. Kruyssen, B.M. de and H.A. Valkenburg, 1989. Decreased selenium levels in acute myocardial infarction. JAMA, 261: 1161-1164.
14. Neve, J., 1996. Selenium as a risk factor for cardiovascular diseases. J. Cardiovasc. Risk, 3: 42-47.
15. Ozata, M., M. Mergen, C. Oktenli, A. Aydin, S.Y. Sanisoglu, E. Bolu, M.I. Yilmaz, A. Sayal, A. Isimer and I.C. Ozdemir, 2002. Increased oxidative stress and hypozincemia in male obesity. Clin. Biochem., 35: 627-631.
16. Paglia, D.E. and W.N. Valentine, 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab Clin. Med., 70: 158-169.
17. Rayman, M.P., 2000. The importance of selenium to human health. Lancet, 356: 233-241.
18. Salonen, J.T., G. Alfthan, J.K. Huttunen, J. Pikkarainen and P. Puska, 1982. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet, 2: 175-179.
19. Salonen, J.T., K. Nyyssonen, T.P. Tuomainen, P.H. Maenpaa, H. Korpela, G.A. Kaplan, J. Lynch, S.P. Helmrich and R. Salonen, 1995. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ, 311: 1124-1127.
20. Thomson, C.D. and M.F. Robinson, 1980. Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. Am. J. Clin. Nutr., 33: 303-323.